KR20080025405A - Ｏ-데스메틸벤라팍신 숙시네이트의 고도로 생체이용가능한경구 지연 방출형 투여 형태 - Google Patents

Ｏ-데스메틸벤라팍신 숙시네이트의 고도로 생체이용가능한경구 지연 방출형 투여 형태 Download PDF

Info

Publication number
KR20080025405A
KR20080025405A KR1020087001067A KR20087001067A KR20080025405A KR 20080025405 A KR20080025405 A KR 20080025405A KR 1020087001067 A KR1020087001067 A KR 1020087001067A KR 20087001067 A KR20087001067 A KR 20087001067A KR 20080025405 A KR20080025405 A KR 20080025405A
Authority
KR
South Korea
Prior art keywords
dvs
composition according
dosage unit
superbioavailable
oral dosage
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
KR1020087001067A
Other languages
English (en)
Korean (ko)
Inventor
시에드 엠 샤
마디 비 포지
크리스토퍼 리차드 디오리오
Original Assignee
와이어쓰
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 와이어쓰 filed Critical 와이어쓰
Publication of KR20080025405A publication Critical patent/KR20080025405A/ko
Withdrawn legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Emergency Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
KR1020087001067A 2005-07-15 2006-07-13 Ｏ-데스메틸벤라팍신 숙시네이트의 고도로 생체이용가능한경구 지연 방출형 투여 형태 Withdrawn KR20080025405A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US69962305P 2005-07-15 2005-07-15
US60/699,623 2005-07-15

Publications (1)

Publication Number Publication Date
KR20080025405A true KR20080025405A (ko) 2008-03-20

Family

ID=37669348

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020087001067A Withdrawn KR20080025405A (ko) 2005-07-15 2006-07-13 Ｏ-데스메틸벤라팍신 숙시네이트의 고도로 생체이용가능한경구 지연 방출형 투여 형태

Country Status (20)

Country Link
US (1) US20070014859A1 (enExample)
EP (1) EP1904040A2 (enExample)
JP (1) JP2009501233A (enExample)
KR (1) KR20080025405A (enExample)
CN (1) CN101247791A (enExample)
AR (1) AR054833A1 (enExample)
AU (1) AU2006270315A1 (enExample)
BR (1) BRPI0613484A2 (enExample)
CA (1) CA2612960A1 (enExample)
CR (1) CR9626A (enExample)
EC (1) ECSP088106A (enExample)
GT (1) GT200600307A (enExample)
IL (1) IL188313A0 (enExample)
MX (1) MX2008000666A (enExample)
NO (1) NO20080088L (enExample)
PE (1) PE20070192A1 (enExample)
RU (1) RU2007148195A (enExample)
SV (1) SV2008002612A (enExample)
TW (1) TW200740427A (enExample)
WO (1) WO2007011619A2 (enExample)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ556673A (en) 2005-02-03 2010-03-26 Gen Hospital Corp Method for treating gefitinib and/or erlotinib resistant cancer with an EGFR inhibitor
ES2335919T3 (es) * 2005-03-31 2010-04-06 Wyeth Producto de combinacion de o-desmetilvenlafaxina y bazedosifeno, y sus usos.
US20080175873A1 (en) * 2005-06-02 2008-07-24 Biovail Laboratories International S.R.L. Modified release composition of at least one form of venlafaxine
EP3488866A1 (en) 2005-11-04 2019-05-29 Wyeth LLC Antineoplastic combinations with mtor inhibitor, herceptin, and/or hki-272
WO2007067501A1 (en) * 2005-12-05 2007-06-14 Wyeth Process for selective synthesis of enantiomers of substituted 1-(2-amino-1-phenyl-ethyl)-cyclohexanols
TW200806282A (en) * 2006-05-05 2008-02-01 Wyeth Corp Solid dosage formulations
US20100210719A1 (en) * 2007-07-12 2010-08-19 Dr. Reddy's Laboratories Ltd. O-desmethylvenlafaxine
US20100330172A1 (en) * 2007-10-16 2010-12-30 Alphapharm Pty Ltd Controlled-release pharmaceutical formulation
US8022216B2 (en) 2007-10-17 2011-09-20 Wyeth Llc Maleate salts of (E)-N-{4-[3-chloro-4-(2-pyridinylmethoxy)anilino]-3-cyano-7-ethoxy-6-quinolinyl}-4-(dimethylamino)-2-butenamide and crystalline forms thereof
US20110027324A1 (en) * 2007-12-10 2011-02-03 Wyeth Llc O-desmethyl-venlafaxine for treating major depressive disorder
ES2531322T3 (es) 2008-06-17 2015-03-13 Wyeth Llc Combinaciones antineoplásicas que contienen HKI-272 y vinorelbina
EP3175853B1 (en) 2008-08-04 2023-11-01 Wyeth LLC Antineoplastic combinations of neratinib and capecitabine
CN101716168B (zh) * 2008-10-09 2014-09-17 北京德众万全医药科技有限公司 一种含有去甲文拉法新的盐的药物组合物及其制备方法
EP2191822A1 (en) * 2008-11-26 2010-06-02 LEK Pharmaceuticals d.d. Controlled release pharmaceutical compositions comprising O-desmethyl-venlafaxine
PT3000467T (pt) 2009-04-06 2023-03-30 Wyeth Llc Regime de tratamento utilizando neratinib para o cancro de mama
EP2498751B1 (en) * 2009-11-09 2019-04-03 Wyeth LLC Coated drug spheroids and uses thereof for eliminating or reducing conditions such as emesis and diarrhea
EP2552419A2 (en) * 2010-03-31 2013-02-06 Wockhardt Limited Modified release dosage form comprising desvenlafaxine or salts thereof
CN102085197B (zh) * 2010-12-14 2013-08-14 北京万生药业有限责任公司 一种文拉法辛缓释制剂及其制备方法
WO2012140577A1 (en) 2011-04-12 2012-10-18 Lupin Limited Modified release pharmaceutical compositions of desvenlafaxine
CN111008356B (zh) * 2019-11-13 2023-06-16 成都理工大学 一种基于WTSVD算法扣除背景的γ能谱集分析方法
CN114288273B (zh) * 2022-02-11 2022-10-18 桂林华信制药有限公司 一种盐酸文拉法辛缓释胶囊及其生产工艺

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6274171B1 (en) * 1996-03-25 2001-08-14 American Home Products Corporation Extended release formulation of venlafaxine hydrochloride
AU5738700A (en) * 1999-06-15 2001-01-02 American Home Products Corporation Enantiomers of o-desmethyl venlafaxine
AR021347A1 (es) * 1999-10-20 2002-07-17 Cipla Ltd Una composicion farmaceutica que contiene acido(s) bisfosfoncio o sal(es) del mismo y un proceso de preparacion de la misma
US20030191347A1 (en) * 2002-03-28 2003-10-09 Rolf Keltjens Venlafaxine base
US6703044B1 (en) * 2002-10-25 2004-03-09 Dexcel Pharma Tech, Ltd Venlafaxine formulations
ES2277030T3 (es) * 2003-05-02 2007-07-01 Dexcel Ltd. Formulacion en comprimidos de venlafaxina de liberacion prolongada.
WO2005077340A1 (en) * 2004-02-06 2005-08-25 Wyeth Multiparticulate o-desmethylvenlafaxine salts and uses thereof
US8394409B2 (en) * 2004-07-01 2013-03-12 Intellipharmaceutics Corp. Controlled extended drug release technology

Also Published As

Publication number Publication date
WO2007011619A2 (en) 2007-01-25
CR9626A (es) 2008-04-10
AR054833A1 (es) 2007-07-18
CA2612960A1 (en) 2007-01-25
GT200600307A (es) 2008-04-24
IL188313A0 (en) 2008-04-13
SV2008002612A (es) 2008-08-29
WO2007011619A3 (en) 2007-06-21
US20070014859A1 (en) 2007-01-18
RU2007148195A (ru) 2009-08-20
BRPI0613484A2 (pt) 2016-11-16
TW200740427A (en) 2007-11-01
JP2009501233A (ja) 2009-01-15
EP1904040A2 (en) 2008-04-02
AU2006270315A1 (en) 2007-01-25
PE20070192A1 (es) 2007-03-16
NO20080088L (no) 2008-04-02
ECSP088106A (es) 2008-02-20
CN101247791A (zh) 2008-08-20
MX2008000666A (es) 2008-03-13

Similar Documents

Publication Publication Date Title
US20070014859A1 (en) Highly bioavailable oral delayed release dosage forms of O-desmethylvenlafaxine succinate
US10512621B2 (en) Methods of treating posttraumatic stress disorder with acamprosate salts
US20050175698A1 (en) Multiparticulate O-desmethylvenlafaxine salts and uses thereof
IL159591A (en) Terbinafine solid dosage forms for oral administration and uses thereof in the preparation of medicaments
US20090220593A1 (en) Extended release dosage forms of quetiapine
WO2014096982A1 (en) Stable pharmaceutical compositions of saxagliptin or salts thereof
CN103690506A (zh) 一种曲司氯铵缓释组合物及其制备方法
US20070134322A1 (en) Modified and pulsatile release pharmaceutical formulations of escitalopram
US20070112075A1 (en) Stable pharmaceutical formulations containing escitalopram and bupropion
EP4622633A1 (en) Modified-release silodosin compositions and use thereof in methods for male contraception
OA22166A (en) Modified-Release Silodosin Compositions And Use Thereof In Methods For Male Contraception.
CA2792352A1 (en) Modified release dosage form comprising desvenlafaxine or salts thereof
MXPA06008933A (en) Multiparticulate o-desmethylvenlafaxine salts and uses thereof
MX2008004862A (es) Formulaciones farmacéuticas estables que contienen escitalopram y bupropion
CA2758657A1 (en) Controlled release formulations of tolterodine and process of manufacturing

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20080114

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
PC1202 Submission of document of withdrawal before decision of registration

Comment text: [Withdrawal of Procedure relating to Patent, etc.] Withdrawal (Abandonment)

Patent event code: PC12021R01D

Patent event date: 20090806

WITB Written withdrawal of application